Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99m Tc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy
Top Cited Papers
- 1 September 2005
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 46 (6) , 1076-1084
- https://doi.org/10.1016/j.jacc.2005.05.073
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Guidelines on the diagnosis and management of AL amyloidosisBritish Journal of Haematology, 2004
- Soft-Tissue Uptake of Tc-99m DPD (Dicarboxypropane Diphosphonate) in AmyloidosisClinical Nuclear Medicine, 1996
- Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotininEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Usefulness of technetium-99m pyrophosphate myocardial scintigraphy in amyloid polyneuropathy and correlation with echocardiographyThe American Journal of Cardiology, 1993
- Soft-tissue uptake of99m-Tc-diphosphonate and99mTc-pyrophosphate in amyloidosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: A study with familial amyloid polyneuropathyAmerican Heart Journal, 1987
- Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosisThe American Journal of Cardiology, 1984
- Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosisThe American Journal of Cardiology, 1983
- Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosisAmerican Heart Journal, 1982
- Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphySeminars in Nuclear Medicine, 1980